![Nicklas Westerholm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicklas Westerholm
Directeur Général chez
EGETIS THERAPEUTICS AB
Fortune : 447 241 $ au 30/09/2026
Profil
Nicklas Westerholm is currently Chief Executive Officer at Egetis Therapeutics AB since 2017, Chairman & Chief Executive Officer at Rare Thyroid Therapeutics International AB, and Independent Director at Spago Nanomedical AB since 2019.
Former positions include Head-Investor Relations at AstraZeneca PLC from 2011 to 2013 and VP-Project & Portfolio Management at AstraZeneca AB from 1995 to 2017.
Education includes undergraduate studies at the University of Stockholm and the Royal Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EGETIS THERAPEUTICS AB 0,11 % | 31/08/2026 | 503 706 ( 0,11 % ) | 447 241 $ | 30/09/2026 |
Postes actifs de Nicklas Westerholm
| Sociétés | Poste | Début |
|---|---|---|
| EGETIS THERAPEUTICS AB | Directeur Général | 16/06/2017 |
| SPAGO NANOMEDICAL AB | Directeur/Membre du Conseil | 08/05/2019 |
Rare Thyroid Therapeutics International AB
 Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Provides thyroid therapeutics research services | Directeur Général | - |
Anciens postes connus de Nicklas Westerholm
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | 01/06/2017 |
| ASTRAZENECA PLC | Investor Relations Contact | 08/09/2011 |
Formation de Nicklas Westerholm
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Egetis Therapeutics AB
 Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Spago Nanomedical AB
 Spago Nanomedical AB BiotechnologyHealth Technology Acts as a biotechnology company | Health Technology |
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Provides thyroid therapeutics research services | Health Technology |
